How shortages have affected compounding permissions posts 61–72
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
I read post #61 twice before replying, because I had assumed the opposite.
Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and resuming when supply returns is different from gradually tapering. The two are different decisions.
This follows post #61 rather than contradicting it.
Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your clinician is prudent if the gap is weeks or longer.
Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and time-limited (usually for the duration of the shortage).
Supply interruptions: official shortage notices are published by regulatory agencies. That is the correct primary source rather than pharmacy rumors or forum discussion.
Picking up post #65: that is the part I would want checked first.
For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
Collapsed as off-topic by two members at trust level 3 or above
Worth separating two things that post #65 runs together.
Shortage predictions: regulators and suppliers issue shortage alerts before they become acute. Checking the regulatory website for shortages gives you advance notice.
Communication from suppliers: a supplier having supply problems usually communicates them. If a supplier goes silent, that is itself information.
Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own records is not any individual result; it is that they are dated and consecutive.
This topic was referenced in
- Coming back to: Official shortage notices and what they authoriseAccess › Shortages · 43 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Hoarding and why it makes a shortage worse
Posting this under the heading it deserves: Hoarding and why it makes a shortage worse Everything below is what sits behind that. Documenting an access outcome, dated, because everything in this category…
|
2 | 12k | 22mo | |
|
Second pass at: Hoarding and why it makes a shortage worse
Second pass at: Hoarding and why it makes a shortage worse Writing it up because I had to work it out twice and would rather nobody else did. Documenting an access outcome, dated, because everything in this…
|
+115 | 133 | 11k | 21mo |
|
Substitution between formats during a shortage — what changed since
Substitution between formats during a shortage — what changed since — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is…
|
+17 | 21 | 2.7k | 9d |
|
Managing an unplanned gap in supply — what changed since
On the subject in the title: Managing an unplanned gap in supply — what changed since Working notes rather than a conclusion. A coverage question with the paperwork detail included, since that is what…
|
+114 | 124 | 54k | 8mo |
|
How shortages have affected compounding permissions — does this still hold?
How shortages have affected compounding permissions — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. A coverage question with the paperwork…
|
+27 | 31 | 21k | 17h |
Related topics — sharing the tags shortage, compounding, FDA
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Follow-up: State-level differences that actually matter
State-level differences that actually matter — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines the…
|
+90 | 96 | 4.1k | 4mo |
|
Coming back to: Official shortage notices and what they authorise
Official shortage notices and what they authorise — setting out what I have, and where I think it stops being reliable. A coverage question with the paperwork detail included, since that is what determines…
|
+39 | 43 | 510 | 17mo |
|
Follow-up: External review after an internal denial
Posting this under the heading it deserves: External review after an internal denial Everything below is what sits behind that. A coverage question with the paperwork detail included, since that is what…
|
+6 | 10 | 12k | 15h |
|
Cost per milligram, computed honestly across formats — the long version
Cost per milligram, computed honestly across formats — the long version Writing it up because I had to work it out twice and would rather nobody else did. A coverage question with the paperwork detail…
|
+111 | 124 | 24k | 14mo |
|
Import rules for personal quantities, by jurisdiction, dated
On the subject in the title: Import rules for personal quantities, by jurisdiction, dated Working notes rather than a conclusion. Structured report rather than an opinion, following the format the maintainers…
|
3 | 60k | 12mo |